All protocols
Repair Stacks

GLOW Peptide Dosage Chart & Blend Protocol

Updated 2mo ago 6 min read 287+ helpful Calculator
Validity Score

Validity Score

31 Speculative
Evidence 42
Community 100
Completeness 71
Actionability 80
Coverage 80
Penalty -34

This score combines formal evidence, page completeness, calculator readiness, and community convergence.

What it is

GLOW is a fixed 70 mg community blend containing GHK-Cu, BPC-157, and TB-500 — the “GLOW peptide” referred to in community discussion is this three-component blend, not a single compound. The formula combines copper-peptide signaling with two experimental repair pathways, but the blend itself does not have a validated human protocol.

Evidence boundary

Community fixed-ratio blend with no human trial validating the combination or its cycle.

Preparation and measurement

Reconstitution: 70 mg vial + 3 mL BAC = 23.33 mg/mL.

Concentration matches.

Reference schedule

Reference schedule
PhaseDoseDraw / measureFrequencyWeekly total
Weeks 1–42.33 mg total blend10 U (0.10 mL)Once daily16.31 mg/week

Weeks 1–4

Dose
2.33 mg total blend
Draw / measure
10 U (0.10 mL)
Frequency
Once daily
Weekly total
16.31 mg/week

Weekly totals apply only during the active phase.

Titration rules

  • The collected schedule uses a fixed 10 U daily draw; no automatic escalation is defined.
  • Changing the draw changes all three components together. Separate vials are required when one component needs adjustment.

Cycle length and breaks

Use a defined 4-week daily block, then stop for 2–4 weeks and reassess.

What to monitor

  • Skin and wound changes documented with consistent photos
  • Pain, swelling, mobility, and injection-site reactions
  • Avoid duplicate standalone GHK-Cu exposure unless the total copper-peptide amount is explicitly calculated

Practical rules

  • Keep wound or injury measurements objective and consistent.
  • Protect healing skin from excess sun exposure.
  • Record the total weekly GHK-Cu exposure when any separate copper-peptide product is used.
Was this protocol helpful?
Share via
Supply & lot verification Availability and batch-linked COA records for GLOW Peptide Dosage Chart & Blend Protocol are tracked with the current supplier listings. View availability & COA →

Dosing Calculator

70 mg + 3 mL BAC · blend · week 1 2.3 mg
LIVE CALCULATIONvolume / concentration / draw
RP–CALC–01
DRAW AMOUNT10 units0.1 mL · U-100
Draw 10 units, equivalent to 0.1 milliliters.
Concentration23.333 mg/mL
Selected dose2.3 mg = 10 units
Enter a desired amount in milligrams or micrograms.
05 Standard amounts
1–10 mg · 0.5 mg steps
06 Suggested doses Select a row
1 unit = 0.01 mL on a U-100 syringe. Values retain decimal precision; visual marks are not silently snapped.
07 cycle summary

Vials required for Cycle

Estimate how much material you need for a full cycle, including cycle length and the number of cycles you plan to run.

Cycle total —
Total required vials —
Total reconstitution —
Total BAC water —
08 projected levels

How the draws stack up

A first-order model of depot absorption and elimination, run on the draws and cadence above. Pick the half-life from whatever your own source documents — this page does not assume one per compound. A planning sketch — not a prediction for any compound or any individual.

Half-life

Modelled level across the cycle. Each spike is one draw.

Accumulation—steady state vs one draw
Peak-to-trough—inside one interval
Steady state—about 4 half-lives
Draws modelled—at this cadence
Vial yieldat the selected amount
Draws per vial—
Lasts—
Volume used—
Limiting factor—
Water matrixsame vial, same amount
WaterStrengthDraw
0.5 mL——
1 mL——
2 mL——
3 mL——
5 mL——

Research Protocols

Keep up to date with latest protocols, updates and offers

An occasional email when a new protocol lands or an existing one is revised. No more than once a month.